Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Dipanjan Banchur

YOU WONT BELIEVE: Are wall street analysts bullish on viatris stock - You Need To See This

Viatris Inc. (VTRS), headquartered in Canonsburg, Pennsylvania, is a global healthcare company that supplies high-quality medicines to approximately 1 billion patients worldwide annually. Valued at $12.54 billion by market cap, the company offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (API). 

Shares of this healthcare company have underperformed the broader market considerably over the past year. VTRS has gained 14% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 27.1%. In 2024, shares of VTRS are down 2.8%, while the SPX is up 10.4% on a YTD basis.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.